Terms: = Breast cancer AND SOX2, MGC2413, 6657, ENSG00000181449, MCOPS3, P48431, ANOP3 AND Prognosis
72 results:
1. Long non-coding RNA sox2OT in tamoxifen-resistant breast cancer.
Lee J; Kim EA; Kang J; Chae YS; Park HY; Kang B; Lee SJ; Lee IH; Park JY; Park NJ; Jung JH
BMC Mol Cell Biol; 2024 Apr; 25(1):12. PubMed ID: 38649821
[TBL] [Abstract] [Full Text] [Related]
2. SIX1 amplification modulates stemness and tumorigenesis in breast cancer.
Guo L; Li F; Liu H; Kong D; Chen C; Sun S
J Transl Med; 2023 Nov; 21(1):866. PubMed ID: 38031089
[TBL] [Abstract] [Full Text] [Related]
3. Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma.
Augustin RC; Newman S; Li A; Joy M; Lyons M; Pham MP; Lucas P; Smith K; Sander C; Isett B; Davar D; Najjar YG; Zarour HM; Kirkwood JM; Luke JJ; Bao R
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37857525
[TBL] [Abstract] [Full Text] [Related]
4. Circular RNA_0000326 accelerates breast cancer development via modulation of the miR-9-3p/YAP1 axis.
Xue XL; Zhao S; Xu MC; Li Y; Liu WF; Qin HZ
Neoplasma; 2023 Jun; 70(3):430-442. PubMed ID: 37498061
[TBL] [Abstract] [Full Text] [Related]
5. Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis.
Zhou T; Xie Y; Hou X; Bai W; Li X; Liu Z; Man Q; Sun J; Fu D; Yan J; Zhang Z; Wang Y; Wang H; Jiang W; Gao S; Zhao T; Chang A; Wang X; Sun H; Zhang X; Yang S; Huang C; Hao J; Liu J
J Exp Clin Cancer Res; 2023 May; 42(1):111. PubMed ID: 37143164
[TBL] [Abstract] [Full Text] [Related]
6. Estrogen Receptor β4 Regulates Chemotherapy Resistance and Induces cancer Stem Cells in Triple Negative breast cancer.
Bano A; Stevens JH; Modi PS; Gustafsson JÅ; Strom AM
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982940
[TBL] [Abstract] [Full Text] [Related]
7. Proteomic profiling and ROC analysis identify CD151 and ELAVL1 as potential therapy response markers for the antiviral drug in resistant TNBC.
Marni R; Malla M; Chakraborty A; Malla R
Life Sci; 2023 May; 320():121534. PubMed ID: 36889667
[TBL] [Abstract] [Full Text] [Related]
8. Expression analysis of novel long non-coding RNAs for invasive ductal and invasive lobular breast carcinoma cases.
Aktan Ç; Küçükaslan AŞ; Türk BA; Yildirim I
Pathol Res Pract; 2023 Apr; 244():154391. PubMed ID: 36868097
[TBL] [Abstract] [Full Text] [Related]
9. Niche stiffness sustains cancer stemness via TAZ and NANOG phase separation.
Liu X; Ye Y; Zhu L; Xiao X; Zhou B; Gu Y; Si H; Liang H; Liu M; Li J; Jiang Q; Li J; Yu S; Ma R; Su S; Liao JY; Zhao Q
Nat Commun; 2023 Jan; 14(1):238. PubMed ID: 36646707
[TBL] [Abstract] [Full Text] [Related]
10. Total flavonoids of Litchi seed attenuate stem cell-like properties in breast cancer by regulating Notch3 signaling pathway.
Liao Y; Luo Z; Liu Y; Xue W; He S; Chen X; Ren H; Yang X; Zhu D; Su Z; Huang Q; Guo H
J Ethnopharmacol; 2023 Apr; 305():116133. PubMed ID: 36603788
[TBL] [Abstract] [Full Text] [Related]
11. Repression of miR-146a in predicting poor treatment outcome in triple-negative breast cancer.
Panoutsopoulou K; Liu Y; Avgeris M; Dreyer T; Dorn J; Magdolen V; Scorilas A
Clin Biochem; 2023 Apr; 114():43-51. PubMed ID: 36502883
[TBL] [Abstract] [Full Text] [Related]
12. GDF15 Contributes to Radioresistance by Mediating the EMT and Stemness of breast cancer Cells.
Zhao X; Liu X; Hu S; Pan Y; Zhang J; Tai G; Shao C
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142823
[TBL] [Abstract] [Full Text] [Related]
13. TGFB2-AS1 inhibits triple-negative breast cancer progression via interaction with SMARCA4 and regulating its targets
Zhou C; Wang D; Li J; Wang Q; Wo L; Zhang X; Hu Z; Wang Z; Zhan M; He M; Hu G; Chen X; Shen K; Chen GQ; Zhao Q
Proc Natl Acad Sci U S A; 2022 Sep; 119(39):e2117988119. PubMed ID: 36126099
[TBL] [Abstract] [Full Text] [Related]
14. Expert tumor annotations and radiomics for locally advanced breast cancer in DCE-MRI for ACRIN 6657/I-SPY1.
Chitalia R; Pati S; Bhalerao M; Thakur SP; Jahani N; Belenky V; McDonald ES; Gibbs J; Newitt DC; Hylton NM; Kontos D; Bakas S
Sci Data; 2022 Jul; 9(1):440. PubMed ID: 35871247
[TBL] [Abstract] [Full Text] [Related]
15. Understanding the function and regulation of sox2 for its therapeutic potential in breast cancer.
Dey A; Kundu M; Das S; Jena BC; Mandal M
Biochim Biophys Acta Rev Cancer; 2022 Mar; 1877(2):188692. PubMed ID: 35122882
[TBL] [Abstract] [Full Text] [Related]
16. Copy number alterations analysis of primary tumor tissue and circulating tumor cells from patients with early-stage triple negative breast cancer.
Silvestri M; Dugo M; Vismara M; De Cecco L; Lanzoni D; Vingiani A; Folli S; De Santis MC; de Braud F; Pruneri G; Di Cosimo S; Cappelletti V
Sci Rep; 2022 Jan; 12(1):1470. PubMed ID: 35087134
[TBL] [Abstract] [Full Text] [Related]
17. THOC2 and THOC5 Regulate Stemness and Radioresistance in Triple-Negative breast cancer.
Bai X; Ni J; Beretov J; Wang S; Dong X; Graham P; Li Y
Adv Sci (Weinh); 2021 Dec; 8(24):e2102658. PubMed ID: 34708581
[TBL] [Abstract] [Full Text] [Related]
18. Atypical cyclin P regulates cancer cell stemness through activation of the WNT pathway.
Sánchez-Botet A; Quandt E; Masip N; Escribá R; Novellasdemunt L; Gasa L; Li VSW; Raya Á; Clotet J; Ribeiro MPC
Cell Oncol (Dordr); 2021 Dec; 44(6):1273-1286. PubMed ID: 34604945
[TBL] [Abstract] [Full Text] [Related]
19. Abnormally elevated ubiquilin‑1 expression in breast cancer regulates metastasis and stemness via AKT signaling.
Feng X; Cao A; Qin T; Zhang Q; Fan S; Wang B; Song B; Yu X; Li L
Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34528694
[TBL] [Abstract] [Full Text] [Related]
20. The frequency and clinical significance of DNA polymerase beta (POLβ) expression in breast ductal carcinoma in situ (DCIS).
Al-Kawaz A; Ali R; Toss MS; Miligy IM; Mohammed OJ; Green AR; Madhusudan S; Rakha EA
Breast Cancer Res Treat; 2021 Nov; 190(1):39-51. PubMed ID: 34406589
[TBL] [Abstract] [Full Text] [Related]
[Next]
